225 studies found for:    "Herpes Zoster" [DISEASE]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Conditions: Herpes Zoster;   Herpes Zoster Vaccine
Interventions: Biological: Herpes zoster vaccine GSK1437173A;   Biological: Placebo
2 Not yet recruiting Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Conditions: Adult;   Shingles;   Herpes Zoster
Interventions: Biological: Zostavax;   Biological: HZ/su vaccine;   Biological: Placebo
3 Completed Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects
Conditions: Herpes Zoster (Shingles);   Shingles
Interventions: Biological: Herpes Zoster vaccine GSK1437173A;   Biological: Placebo
4 Completed A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Conditions: Herpes Zoster;   Shingles
Interventions: Drug: valacyclovir;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
5 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination
6 Completed A Study of an Investigational V212/Heat-Treated VZV Vaccine in Immunocompromised Adults (V212-002)(COMPLETED)
Conditions: Herpes Zoster;   Herpes Zoster-related Complications
Interventions: Biological: Comparator: V212;   Biological: Comparator: Placebo
7 Active, not recruiting Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster vaccine (GSK1437173A)
8 Completed Immune Response to Varicella-Zoster Vaccination and Infection
Conditions: Chickenpox;   Herpes Zoster
Intervention:
9 Completed Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
Conditions: Chickenpox;   Herpes Zoster
Intervention: Drug: famciclovir
10 Unknown  Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Drug: ARYS-01 (sorivudine) cream 3% or placebo cream;   Drug: placebo;   Drug: valaciclovir
11 Completed Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
Conditions: Viral Hepatitis Vaccines;   Hepatitis A;   Cytomegalovirus;   Varicella-Zoster Virus;   Bordetella Pertussis Infection;   Herpes Simplex (1 and 2)
Intervention: Other: Serum sample
12 Active, not recruiting ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: ZOSTAVAX™
13 Completed Shingles Prevention Study
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Biological: Varicella-zoster vaccine;   Biological: Placebo
14 Completed A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
Condition: Herpes Zoster
Interventions: Drug: EPB-348;   Drug: Valacyclovir
15 Recruiting Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Conditions: Herpes Zoster;   Postherpetic Neuralgia;   Pain
Interventions: Device: Sham-laser acupuncture;   Drug: gabapentine;   Procedure: Acupuncture
16 Completed
Has Results
A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Comparator: Zostavax™;   Biological: Comparator: Placebo;   Other: VZV Skin Test;   Other: Saline
17 Completed
Has Results
Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital
Condition: Herpes Zoster
Intervention: Other: Choosing to receive the vaccine
18 Completed
Has Results
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
Condition: Herpes Zoster
Interventions: Biological: zoster vaccine live (ZOSTAVAX™);   Biological: Comparator: Placebo
19 Completed Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK 1437173A
20 Active, not recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
Condition: Herpes Zoster
Interventions: Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A);   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years